Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

  • Field
  • Drug Design Development and Therapy, July 2010, Taylor & Francis
  • DOI: 10.2147/dddt.s7667

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.2147/dddt.s7667